Reach your care team with questions about dosing, side effects, or your progress
Consequently, it may ameliorate ischemic stroke in diabetic mice (224)
In vitro experiments confirmed that A 25-35 treatment significantly inhibited the activation of the NRF2/SLC7A11/GPX4 signaling pathway in HT22 cells, upregulated the expression of Fe 2+ , TFR1, ACSL4, MDA, and GSSG, and decreased the expression of FTH1, SOD, and GSH, as well as the GSH/GSSG ratio, resulting in dysregulated neuronal iron metabolism, impaired amino acid antioxidant systems, mitochondrial dysfunction, and ferroptosis, which ultimately promoted neuronal injury
Ocadiz-DelgadoRSerafin-HigueraNAlvarez-RiosEGarca-VillaETinajero-RodrguezMRodrguez-UribeGet al